-transparent.png){kind=logo}
Herpes zoster oticus produces facial paralysis with a low recovery rate. Acyclovir, a specific virostatic drug, was given intravenously in five herpes zoster oticus patients, and in three of them was followed by oral therapy. In follow-ups of 1 to 24 months, one patient had grade I recovery, three patients grade II, and one grade III. These good results encourage the use of acyclovir in herpes zoster oticus patients.
Related Publications
N Uri, and
E Greenberg, and
W Meyer, and
R Kitzes-Cohen
July 1988,
The Laryngoscope,
N Uri, and
E Greenberg, and
W Meyer, and
R Kitzes-Cohen
May 1985,
Lancet (London, England),
N Uri, and
E Greenberg, and
W Meyer, and
R Kitzes-Cohen
March 1989,
Laryngo- rhino- otologie,
N Uri, and
E Greenberg, and
W Meyer, and
R Kitzes-Cohen
January 1955,
Otolaryngologia polska = The Polish otolaryngology,
N Uri, and
E Greenberg, and
W Meyer, and
R Kitzes-Cohen
November 1968,
The Laryngoscope,
N Uri, and
E Greenberg, and
W Meyer, and
R Kitzes-Cohen
January 1973,
Zhurnal ushnykh, nosovykh i gorlovykh boleznei = The journal of otology, rhinology, and laryngologie [sic],
N Uri, and
E Greenberg, and
W Meyer, and
R Kitzes-Cohen
January 1962,
Otolaryngologia polska = The Polish otolaryngology,
N Uri, and
E Greenberg, and
W Meyer, and
R Kitzes-Cohen
December 1959,
Nordisk medicin,
N Uri, and
E Greenberg, and
W Meyer, and
R Kitzes-Cohen
October 2021,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
N Uri, and
E Greenberg, and
W Meyer, and
R Kitzes-Cohen
December 1970,
Archives of otolaryngology (Chicago, Ill. : 1960),
